[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

Autonomix has patented technology that can detect and target nerve signals at an accuracy never seen before, a $100B opportunity. Now the team with almost $600M in exits is planning to list Autonomix on the Nasdaq. And you can invest in Autonomix ahead of their intended Nasdaq listing.* *Disclosure: This is a paid advertisement for Autonomix’s Regulation A+ Offering. Please read the offering circular at invest.autonomix.com

KURA Insider Trading

Insider Trading Chart
Insider Trading History
Frequently Asked Questions
About

Insider Ownership Percentage: 5.60%

Insider Buying (Last 12 Months): $575,000.00

Insider Selling (Last 12 Months): $73,269.75

Kura Oncology Insider Trading History Chart

Kura Oncology Share Price & Price History

^$9.49

▲ +0.05 (0.53%)

As of 11/29/2023 01:00 AM ET

Days: 30 | 90 | 365

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

Kura Oncology Insider Trading History

Transaction Date	Insider Name	Title	Buy/Sell	Number of Shares	Average Share Price	Total Transaction	Shares Held After Transaction
6/16/2023	Thomas Malley	Director	Buy	50,000	$11.50	$575,000.00	139,557
1/27/2023	Kathleen Ford	COO	Sell	1,821	$13.89	$25,293.69	21,214
1/27/2023	Kirsten Flowers	Insider	Sell	1,906	$13.89	$26,474.34	20,605
1/27/2023	Thomas James Doyle	SVP	Sell	1,548	$13.89	$21,501.72	16,841
3/15/2021	Kathleen Ford	COO	Sell	6,250	$29.43	$183,937.50	6,250

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

SEC Filings (Institutional Ownership Changes) for Kura Oncology (NASDAQ:KURA)

Institutional Buying and Selling by Quarter

Kura Oncology Institutional Trading History

Reporting Date	Hedge Fund	Shares Held	Market Value	% of Portfolio	Quarterly Change in Shares	Ownership in Company
11/24/2023	Deutsche Bank AG	31,688	$0.29M	0.0%	+16.7%	0.043%
11/22/2023	Graham Capital Management L.P.	21,131	$0.19M	0.0%	-31.0%	0.028%
11/21/2023	Walleye Capital LLC	264,893	$2.42M	0.0%	+220.4%	0.357%
11/15/2023	The Manufacturers Life Insurance Company	26,871	$0.25M	0.0%	+4.3%	0.036%
11/15/2023	GSA Capital Partners LLP	11,039	$0.10M	0.0%	-89.9%	0.015%
11/15/2023	Alethea Capital Management LLC	350,445	$3.20M	3.9%	+5.1%	0.472%
11/15/2023	Acuta Capital Partners LLC	702,093	$6.40M	4.3%	-1.0%	0.945%
11/15/2023	Alps Advisors Inc.	54,749	$0.50M	0.0%	+8.8%	0.074%
11/15/2023	Armistice Capital LLC	2,236,000	$20.39M	0.3%	+5.3%	3.011%
11/15/2023	AXQ Capital LP	12,943	$0.12M	0.0%	N/A	0.017%
11/15/2023	Affinity Asset Advisors LLC	856,535	$7.81M	2.2%	-5.9%	1.153%
11/15/2023	AQR Capital Management LLC	110,639	$1.01M	0.0%	+696.2%	0.149%
11/14/2023	Deerfield Management Company L.P. Series C	4,374,044	$39.89M	0.9%	+35.1%	5.889%
11/14/2023	California State Teachers Retirement System	64,686	$0.59M	0.0%	-3.2%	0.087%
11/14/2023	Tower Research Capital LLC TRC	3,575	$33K	0.0%	-24.1%	0.005%
11/14/2023	Trexquant Investment LP	36,715	$0.34M	0.0%	-55.9%	0.049%
11/14/2023	Profund Advisors LLC	39,621	$0.36M	0.0%	+8.9%	0.053%
11/14/2023	Pale Fire Capital SE	10,050	$92K	0.0%	N/A	0.014%
11/13/2023	Algert Global LLC	365,024	$3.33M	0.2%	+95.1%	0.491%
11/13/2023	Northern Trust Corp	705,378	$6.43M	0.0%	+12.5%	0.950%
11/13/2023	Dark Forest Capital Management LP	80,162	$0.73M	0.1%	N/A	0.108%
11/13/2023	Hsbc Holdings PLC	33,237	$0.30M	0.0%	N/A	0.045%
11/13/2023	FMR LLC	70,479	$0.64M	0.0%	+6.5%	0.095%
11/13/2023	Rafferty Asset Management LLC	232,207	$2.12M	0.0%	+17.5%	0.313%
11/13/2023	DekaBank Deutsche Girozentrale	30,000	$0.26M	0.0%	N/A	0.040%
11/13/2023	E Fund Management Co. Ltd.	11,929	$0.11M	0.0%	+12.2%	0.016%
11/9/2023	Rhumbline Advisers	110,876	$1.01M	0.0%	+5.0%	0.149%
11/9/2023	Deutsche Bank AG	31,688	$0.29M	0.0%	+16.7%	0.043%
11/9/2023	Citigroup Inc.	98,557	$0.90M	0.0%	+29.3%	0.133%
11/9/2023	UBS Group AG	82,345	$0.75M	0.0%	+484,282.4%	0.111%
11/9/2023	Jupiter Asset Management Ltd.	57,877	$0.53M	0.0%	+234.2%	0.078%
11/8/2023	Charles Schwab Investment Management Inc.	563,421	$5.14M	0.0%	+18.0%	0.759%
11/8/2023	Swiss National Bank	122,100	$1.11M	0.0%	+6.9%	0.164%
11/7/2023	New York State Common Retirement Fund	23,643	$0.22M	0.0%	+29.1%	0.032%
11/7/2023	Barclays PLC	155,245	$1.42M	0.0%	+27.0%	0.209%
11/7/2023	Jump Financial LLC	49,614	$0.45M	0.0%	N/A	0.067%
11/7/2023	Arizona State Retirement System	15,823	$0.14M	0.0%	+9.8%	0.021%
11/2/2023	Principal Financial Group Inc.	21,464	$0.20M	0.0%	+22.0%	0.029%
10/31/2023	Teacher Retirement System of Texas	15,490	$0.14M	0.0%	+11.1%	0.021%
10/27/2023	Hennion & Walsh Asset Management Inc.	50,700	$0.46M	0.0%	+4.1%	0.068%
10/26/2023	Inspire Advisors LLC	37,698	$0.34M	0.1%	-50.3%	0.051%
10/24/2023	Bank of New York Mellon Corp	261,744	$2.39M	0.0%	+10.9%	0.353%
10/19/2023	Aaron Wealth Advisors LLC	52,196	$0.48M	0.1%	-7.8%	0.070%
8/21/2023	Affinity Asset Advisors LLC	910,317	$9.63M	3.3%	+154.8%	1.226%
8/21/2023	California State Teachers Retirement System	66,836	$0.71M	0.0%	-11.1%	0.090%
8/15/2023	Alliancebernstein L.P.	205,100	$2.17M	0.0%	+156.1%	0.276%
8/15/2023	Wells Fargo & Company MN	58,457	$0.62M	0.0%	-20.6%	0.079%
8/15/2023	Walleye Capital LLC	82,672	$0.88M	0.0%	N/A	0.111%
8/15/2023	Woodline Partners LP	867,062	$9.17M	0.1%	+77.1%	1.168%
8/15/2023	Goldman Sachs Group Inc.	930,358	$9.84M	0.0%	-14.4%	1.253%
8/15/2023	Alethea Capital Management LLC	333,445	$3.53M	3.8%	-8.3%	0.449%
8/15/2023	Readystate Asset Management LP	46,741	$0.50M	0.0%	N/A	0.063%
8/15/2023	Royal Bank of Canada	6,801	$72K	0.0%	+81.5%	0.009%
8/15/2023	Suvretta Capital Management LLC	7,028,442	$74.36M	4.0%	+6.9%	9.467%
8/15/2023	HighVista Strategies LLC	52,787	$0.56M	0.3%	+80.5%	0.071%
8/15/2023	Commodore Capital LP	1,400,000	$14.81M	1.7%	+16.2%	1.886%
8/14/2023	Tudor Investment Corp Et Al	34,839	$0.37M	0.0%	N/A	0.047%
8/14/2023	Tower Research Capital LLC TRC	4,710	$50K	0.0%	+46.8%	0.006%
8/14/2023	Marshall Wace LLP	80,004	$0.85M	0.0%	N/A	0.108%
8/14/2023	State of Wisconsin Investment Board	50,422	$0.53M	0.0%	-5.7%	0.068%
8/14/2023	State Street Corp	3,013,148	$31.88M	0.0%	-21.6%	4.059%
8/14/2023	Caption Management LLC	111,023	$1.18M	0.0%	N/A	0.150%
8/14/2023	Prosight Management LP	1,343,359	$14.21M	4.4%	N/A	1.809%
8/14/2023	Ghisallo Capital Management LLC	45,000	$0.48M	0.1%	N/A	0.061%
8/14/2023	Thrivent Financial for Lutherans	66,176	$0.70M	0.0%	-14.1%	0.089%
8/14/2023	Graham Capital Management L.P.	30,618	$0.32M	0.0%	N/A	0.041%
8/11/2023	Renaissance Technologies LLC	188,100	$1.99M	0.0%	+1,033.1%	0.275%
8/11/2023	Credit Suisse AG	79,610	$0.84M	0.0%	+10.7%	0.116%
8/11/2023	BlackRock Inc.	6,157,402	$65.15M	0.0%	+14.7%	8.997%
8/11/2023	MYDA Advisors LLC	80,000	$0.85M	0.3%	+300.0%	0.117%
8/11/2023	Campbell & CO Investment Adviser LLC	17,123	$0.18M	0.0%	N/A	0.025%
8/11/2023	The Manufacturers Life Insurance Company	25,756	$0.27M	0.0%	+4.8%	0.038%
8/11/2023	Franklin Resources Inc.	1,224,497	$12.96M	0.0%	+2.8%	1.789%
8/11/2023	Trexquant Investment LP	83,323	$0.88M	0.0%	N/A	0.122%
8/11/2023	Geode Capital Management LLC	1,328,116	$14.05M	0.0%	+3.2%	1.941%
8/11/2023	Artal Group S.A.	2,018,056	$21.35M	0.7%	+17.5%	2.949%
8/11/2023	E Fund Management Co. Ltd.	10,628	$0.11M	0.0%	-31.8%	0.016%
8/11/2023	JPMorgan Chase & Co.	502,451	$5.32M	0.0%	-2.1%	0.734%
8/11/2023	Northern Trust Corp	626,886	$6.63M	0.0%	-1.0%	0.916%
8/11/2023	ExodusPoint Capital Management LP	30,624	$0.32M	0.0%	-73.9%	0.045%
8/10/2023	Monashee Investment Management LLC	120,000	$1.27M	0.3%	N/A	0.175%
8/10/2023	Profund Advisors LLC	36,393	$0.39M	0.0%	-28.9%	0.053%
8/10/2023	Mirae Asset Global Investments Co. Ltd.	37,613	$0.40M	0.0%	-9.1%	0.055%
8/10/2023	Russell Investments Group Ltd.	142,505	$1.51M	0.0%	+63.9%	0.208%
8/10/2023	Jupiter Asset Management Ltd.	17,317	$0.18M	0.0%	N/A	0.025%
8/10/2023	Charles Schwab Investment Management Inc.	477,280	$5.05M	0.0%	+1.3%	0.697%
8/10/2023	Citigroup Inc.	76,200	$0.81M	0.0%	-65.5%	0.111%
8/9/2023	Dimensional Fund Advisors LP	1,911,656	$20.22M	0.0%	+4.2%	2.793%
8/9/2023	BNP Paribas Arbitrage SNC	58,931	$0.62M	0.0%	-48.5%	0.086%
8/9/2023	Swiss National Bank	114,200	$1.21M	0.0%	-8.9%	0.167%
8/8/2023	Rhumbline Advisers	105,616	$1.12M	0.0%	+1.6%	0.154%
8/8/2023	Candriam S.C.A.	691,422	$7.32M	0.1%	-15.1%	1.010%
8/3/2023	Barclays PLC	122,267	$1.29M	0.0%	-46.2%	0.165%
8/3/2023	Bank of New York Mellon Corp	236,067	$2.50M	0.0%	+4.7%	0.345%
8/1/2023	Arizona State Retirement System	14,417	$0.15M	0.0%	-14.2%	0.021%
7/31/2023	Inspire Investing LLC	25,905	$0.27M	0.0%	+5.0%	0.038%
7/31/2023	Inspire Advisors LLC	75,888	$0.80M	0.2%	+14.6%	0.111%
7/27/2023	Virtu Financial LLC	12,233	$0.13M	0.0%	N/A	0.018%
7/20/2023	Exchange Traded Concepts LLC	11,175	$0.12M	0.0%	N/A	0.016%
7/19/2023	Teacher Retirement System of Texas	13,946	$0.15M	0.0%	-22.0%	0.020%

Data available starting January 2016

Kura Oncology, Inc., a clinical-stage biopharmaceutical company, develops medicines for the treatment of cancer in the United States. The company's pipeline consists of small molecule product candidates that target cancer. Its lead product candidates are ziftomenib, a small molecule inhibitor of the menin-Lysine K-specific Methyltransferase 2A protein-protein interaction for the treatment of genetically defined subsets of acute leukemias, including acute myeloid leukemia and acute lymphoblastic leukemia; and tipifarnib, an orally bioavailable inhibitor of farnesyl transferase for the treatment of solid tumors and hematologic indications. The company has a clinical collaboration with Novartis to evaluate the combination of tipifarnib and alpelisib in patients with head and neck squamous cell carcinoma whose tumors have HRAS overexpression or PIK3CA mutation and/or amplification. Kura Oncology, Inc. was founded in 2014 and is headquartered in San Diego, California.

Today's Range

Now: $9.49

$9.48

$9.94

50 Day Range

MA: $8.75

$7.58

$9.56

52 Week Range

Now: $9.49

$7.41

$16.14

Volume

297,510 shs

Average Volume

723,867 shs

Market Capitalization

$704.82 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

0.65

Who are the company insiders with the largest holdings of Kura Oncology?: Kura Oncology's top insider shareholders include:
Thomas Malley (Director)
Kathleen Ford (COO)
Kirsten Flowers (Insider)
Thomas James Doyle (SVP)
Learn More about top insider investors at Kura Oncology.
Who are the major institutional investors of Kura Oncology?: Kura Oncology's top institutional shareholders include:
Deerfield Management Company L.P. Series C — 5.89%
Armistice Capital LLC — 3.01%
Affinity Asset Advisors LLC — 1.15%
Northern Trust Corp — 0.95%
Acuta Capital Partners LLC — 0.95%
Charles Schwab Investment Management Inc. — 0.76%
Learn More about top institutional investors of Kura Oncology stock.
Which institutional investors are selling Kura Oncology stock?: In the previous quarter, KURA stock was sold by these institutional investors:
GSA Capital Partners LLP
Affinity Asset Advisors LLC
Trexquant Investment LP
Inspire Advisors LLC
Graham Capital Management L.P.
Acuta Capital Partners LLC
Aaron Wealth Advisors LLC
Simplex Trading LLC
During the previous year, company insiders that have sold Kura Oncology company stock include:
Thomas Malley (Director)
Kathleen Ford (COO)
Kirsten Flowers (Insider)
Learn More investors selling Kura Oncology stock.
Which institutional investors are buying Kura Oncology stock?: During the previous quarter, KURA stock was bought by institutional investors including:
Deerfield Management Company L.P. Series C
Walleye Capital LLC
Algert Global LLC
Armistice Capital LLC
AQR Capital Management LLC
Charles Schwab Investment Management Inc.
UBS Group AG
Dark Forest Capital Management LP

[Investor Alert] Potential Breakthrough Medical Tech Investment Opportunity

From Autonomix | Ad

Invest in Autonomix today.

KURA Insider Trading

Kura Oncology Insider Trading History Chart

Kura Oncology Share Price & Price History

Kura Oncology Insider Trading History

SEC Filings (Institutional Ownership Changes) for Kura Oncology (NASDAQ:KURA)

Institutional Buying and Selling by Quarter

Kura Oncology Institutional Trading History

Today's Range

50 Day Range

52 Week Range

Volume

Average Volume

Market Capitalization

P/E Ratio

Dividend Yield

Beta

Who are the company insiders with the largest holdings of Kura Oncology?

Who are the major institutional investors of Kura Oncology?

Which institutional investors are selling Kura Oncology stock?

Which institutional investors are buying Kura Oncology stock?